Inducible binding of PU.1 and interacting proteins to the Toll-like receptor 4 promoter during endotoxemia.

We hypothesized that PU.1 and PU.1 interacting proteins (PIP) binding to the Toll-like receptor 4 (TLR4) promoter is involved in endotoxin-induced upregulation of TLR4 gene expression. Our results employing chromatin immunoprecipitation assays indicate that PU.1 binds to the murine TLR4 promoter both in macrophage cells and, most importantly, in whole lung tissue. Treatment of RAW 264.7 cells with endotoxin induced the association of PU.1 and the TLR4 promoter in a time-dependent manner, and this was closely tied to interactions between the TLR4 promoter and the PIP interferon regulatory factors (IRF)4 and IRF8. PU.1 binding was related to increases in steady-state TLR4 mRNA and total TLR4 protein in RAW cells. Endotoxemia in animals caused the similar inducible interaction between PU.1 and IRF4 and the TLR4 promoter in lung tissue of mice that was treated with a single intraperitoneal injection of endotoxin. PU.1 binding to the TLR4 promoter was not enhanced in the lung tissue of endotoxin-resistant C3H/HeJ mice in response to endotoxemia. Transient transfection studies in RAW cells indicate that inducible binding of PU.1 to the TLR4 promoter is abrogated by a Ser148 to Ala mutation in PU.1. These data suggest that induction of PU.1/PIP binding to the TLR4 promoter is involved in endotoxin response in vivo and may mediate transcriptional changes in TLR4 gene expression.

[1]  K. Ozato,et al.  The interferon regulatory factor ICSBP/IRF-8 in combination with PU.1 up-regulates expression of tumor suppressor p15(Ink4b) in murine myeloid cells. , 2004, Blood.

[2]  A. Medford,et al.  Differential expression of Toll‐like receptor (TLR)‐2 and TLR‐4 on monocytes in human sepsis , 2004, Clinical and experimental immunology.

[3]  A. Medford,et al.  Expression of functional toll-like receptor-2 and -4 on alveolar epithelial cells. , 2004, American journal of respiratory cell and molecular biology.

[4]  J. Christman,et al.  Transcriptional Regulation of the Cyclooxygenase-2 Gene in Macrophages by PU.1* , 2004, Journal of Biological Chemistry.

[5]  L. Guillot,et al.  Response of Human Pulmonary Epithelial Cells to Lipopolysaccharide Involves Toll-like Receptor 4 (TLR4)-dependent Signaling Pathways , 2004, Journal of Biological Chemistry.

[6]  S. Gordon,et al.  Multiple Ets Factors and Interferon Regulatory Factor-4 Modulate CD68 Expression in a Cell Type-specific Manner* , 2003, Journal of Biological Chemistry.

[7]  Y. Sugiyama,et al.  Gene expression of Toll-like receptors and associated molecules induced by inflammatory stimuli in the primary alveolar macrophage. , 2003, Biochemical and biophysical research communications.

[8]  M. Muroi,et al.  MD-2 Is Necessary for the Toll-Like Receptor 4 Protein To Undergo Glycosylation Essential for Its Translocation to the Cell Surface , 2003, Clinical Diagnostic Laboratory Immunology.

[9]  Jae-Geun Yoon,et al.  CpG DNA Induces Self and Cross-Hyporesponsiveness of RAW264.7 Cells in Response to CpG DNA and Lipopolysaccharide: Alterations in IL-1 Receptor-Associated Kinase Expression1 , 2003, The Journal of Immunology.

[10]  Douglas T. Golenbock,et al.  Lipopolysaccharide Rapidly Traffics to and from the Golgi Apparatus with the Toll-like Receptor 4-MD-2-CD14 Complex in a Process That Is Distinct from the Initiation of Signal Transduction* 210 , 2002, The Journal of Biological Chemistry.

[11]  A. Brass,et al.  Crystal structure of PU.1/IRF-4/DNA ternary complex. , 2002, Molecular cell.

[12]  L. Farkas,et al.  Differences in LPS‐Induced Activation of Bronchial Epithelial Cells (BEAS‐2B) and Type II‐Like Pneumocytes (A‐549) , 2002, Scandinavian journal of immunology.

[13]  F. Re,et al.  Monomeric Recombinant MD-2 Binds Toll-like Receptor 4 Tightly and Confers Lipopolysaccharide Responsiveness* , 2002, The Journal of Biological Chemistry.

[14]  H. Hauser,et al.  IFN-Stimulated Gene 15 Is Synergistically Activated Through Interactions Between the Myelocyte/Lymphocyte-Specific Transcription Factors, PU.1, IFN Regulatory Factor-8/IFN Consensus Sequence Binding Protein, and IFN Regulatory Factor-4: Characterization of a New Subtype of IFN-Stimulated Response El , 2002, The Journal of Immunology.

[15]  S. Akira,et al.  Essential role of MD-2 in LPS responsiveness and TLR4 distribution , 2002, Nature Immunology.

[16]  J. Marshall,et al.  Regulation of Toll-Like Receptor 4 Expression in the Lung Following Hemorrhagic Shock and Lipopolysaccharide1 , 2002, The Journal of Immunology.

[17]  S. Dower,et al.  Toll-Like Receptor (TLR)2 and TLR4 in Human Peripheral Blood Granulocytes: A Critical Role for Monocytes in Leukocyte Lipopolysaccharide Responses1 , 2002, The Journal of Immunology.

[18]  T. Calandra,et al.  MIF regulates innate immune responses through modulation of Toll-like receptor 4 , 2001, Nature.

[19]  M. Klemsz,et al.  Loss of PU.1 Expression Following Inhibition of Histone Deacetylases1 , 2001, The Journal of Immunology.

[20]  K. Izuhara,et al.  PKCδ and ζ Mediate IL-4/IL-13-Induced Germline ϵ Transcription in Human B Cells: A Putative Regulation via PU.1 Phosphorylation , 2001 .

[21]  A. Visintin,et al.  Secreted MD-2 is a large polymeric protein that efficiently confers lipopolysaccharide sensitivity to Toll-like receptor 4 , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[22]  J. Whitsett,et al.  GM-CSF regulates alveolar macrophage differentiation and innate immunity in the lung through PU.1. , 2001, Immunity.

[23]  Michael D. Liang,et al.  Gene b IL-1Transcriptional Activation of the Human Proteins Synergize to Mediate PU.1 and Multiple IFN Regulatory Factor , 2001 .

[24]  B. Beutler,et al.  Identification of Toll-like receptor 4 (Tlr4) as the sole conduit for LPS signal transduction: genetic and evolutionary studies. , 2001 .

[25]  K. Izuhara,et al.  PKCdelta and zeta mediate IL-4/IL-13-induced germline epsilon transcription in human B cells: a putative regulation via PU.1 phosphorylation. , 2001, Biochemical and biophysical research communications.

[26]  S. Randell,et al.  CD14-dependent Lipopolysaccharide-induced β-Defensin-2 Expression in Human Tracheobronchial Epithelium* , 2000, The Journal of Biological Chemistry.

[27]  P. Allavena,et al.  Differential Expression and Regulation of Toll-Like Receptors (TLR) in Human Leukocytes: Selective Expression of TLR3 in Dendritic Cells1 , 2000, The Journal of Immunology.

[28]  H. Singh,et al.  Regulation of B lymphocyte and macrophage development by graded expression of PU.1. , 2000, Science.

[29]  K. Takeda,et al.  Cutting Edge: Cell Surface Expression and Lipopolysaccharide Signaling Via the Toll-Like Receptor 4-MD-2 Complex on Mouse Peritoneal Macrophages1 , 2000, The Journal of Immunology.

[30]  S. Akira,et al.  Cutting Edge: Endotoxin Tolerance in Mouse Peritoneal Macrophages Correlates with Down-Regulation of Surface Toll-Like Receptor 4 Expression1 , 2000, The Journal of Immunology.

[31]  L. Schwarzfischer,et al.  PU.1 and Interferon Consensus Sequence-binding Protein Regulate the Myeloid Expression of the Human Toll-like Receptor 4 Gene* , 2000, The Journal of Biological Chemistry.

[32]  J. Waring,et al.  Interferon consensus sequence binding protein and interferon regulatory factor-4/Pip form a complex that represses the expression of the interferon-stimulated gene-15 in macrophages. , 1999, Blood.

[33]  E. Eklund,et al.  Recruitment of CREB-binding protein by PU.1, IFN-regulatory factor-1, and the IFN consensus sequence-binding protein is necessary for IFN-gamma-induced p67phox and gp91phox expression. , 1999, Journal of immunology.

[34]  S. Mckercher,et al.  The transcription factor PU.1 does not regulate lineage commitment but has lineage‐specific effects , 1999, Journal of leukocyte biology.

[35]  J. Christman,et al.  Differential NF-κB activation after intratracheal endotoxin. , 1999, American journal of physiology. Lung cellular and molecular physiology.

[36]  M. Atchison,et al.  Differential expression and distinct functions of IFN regulatory factor 4 and IFN consensus sequence binding protein in macrophages. , 1999, Journal of immunology.

[37]  Yoshinori Nagai,et al.  MD-2, a Molecule that Confers Lipopolysaccharide Responsiveness on Toll-like Receptor 4 , 1999, The Journal of experimental medicine.

[38]  L. Larivière,et al.  Cutting edge: functional characterization of the effect of the C3H/HeJ defect in mice that lack an Lpsn gene: in vivo evidence for a dominant negative mutation. , 1999, Journal of immunology.

[39]  S. Akira,et al.  Cutting edge: Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the Lps gene product. , 1999, Journal of immunology.

[40]  M. Rothe,et al.  Bacterial Lipopolysaccharide Activates Nuclear Factor-κB through Interleukin-1 Signaling Mediators in Cultured Human Dermal Endothelial Cells and Mononuclear Phagocytes* , 1999, The Journal of Biological Chemistry.

[41]  R. Maki,et al.  Mutation analysis of the Pip interaction domain reveals critical residues for protein-protein interactions. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[42]  A. Brass,et al.  Assembly requirements of PU.1–Pip (IRF‐4) activator complexes: inhibiting function in vivo using fused dimers , 1999, The EMBO journal.

[43]  L. Larivière,et al.  Endotoxin-tolerant Mice Have Mutations in Toll-like Receptor 4 (Tlr4) , 1999, The Journal of experimental medicine.

[44]  P. Ricciardi-Castagnoli,et al.  Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. , 1998, Science.

[45]  J. Perkel,et al.  A two-step mechanism for recruitment of Pip by PU.1. , 1998, Journal of immunology.

[46]  B. Lucas,et al.  PU.1/Pip and basic helix loop helix zipper transcription factors interact with binding sites in the CD20 promoter to help confer lineage- and stage-specific expression of CD20 in B lymphocytes. , 1997, Blood.

[47]  R. Maki,et al.  Stimulation of macrophages by lipopolysaccharide alters the phosphorylation state, conformation, and function of PU.1 via activation of casein kinase II. , 1997, Journal of immunology.

[48]  A. Feeney,et al.  Targeted disruption of the PU.1 gene results in multiple hematopoietic abnormalities. , 1996, The EMBO journal.

[49]  U. Storb,et al.  Pip, a novel IRF family member, is a lymphoid-specific, PU.1-dependent transcriptional activator. , 1995, Genes & development.

[50]  U. Storb,et al.  PU.1 is a component of a multiprotein complex which binds an essential site in the murine immunoglobulin lambda 2-4 enhancer , 1993, Molecular and cellular biology.

[51]  M. Klemsz,et al.  Effect of PU.1 phosphorylation on interaction with NF-EM5 and transcriptional activation. , 1993, Science.

[52]  M. Klemsz,et al.  PU.1 recruits a second nuclear factor to a site important for immunoglobulin kappa 3' enhancer activity , 1992, Molecular and cellular biology.